Oxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literature
- Authors:
- Shoichiro Ohta
- Yukiko Cho
- Shinji Oshima
- Osamu Hosoya
- Kazuhiko Juni
- Hiroshi Kojima
View Affiliations
Affiliations: Department of Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan, Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan
- Published online on: March 23, 2012 https://doi.org/10.3892/ol.2012.653
-
Pages:
1297-1300
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
We report the case of a woman who developed acute thrombocytopenia with hemorrhagic diathesis during adjuvant treatment of colorectal adenocarcinoma with oxaliplatin, 5-fluorouracil and leucovorin. A 55-year-old woman started adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6). Prior to starting the 12th course of chemotherapy, a complete blood cell count showed the following values: neutrophils 1800/mm3, platelets 136,000/m3 and hemoglobin 11.1 g/dl. A blood count revealed that the platelet levels had dropped to 35,000/mm3, with no significant changes in hemoglobin levels following the course. The administration of corticosteroids was begun and the platelet number was recovered. Clinicians should be aware of the possibility of oxaliplatin-induced hematological emergencies during the treatment of colorectal cancer patients in order to optimize supportive treatment and avoid toxic mortality.
View References
|
1
|
Laurie JA, Moertel CG, Fleming TR, et al:
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation
of levamisole and the combination of levamisole and fluorouracil.
The North Central Cancer Treatment Group and the Mayo Clinic. J
Clin Oncol. 7:1447–1456. 1989.
|
|
2
|
Kanemitsu Y, Kato T, Shimizu Y, et al: A
randomized phase II/III trial comparing hepatectomy followed by
mFOLFOX6 with hepatectomy alone as treatment for liver metastasis
from colorectal cancer: Japan Clinical Oncology Group Study
JCOG0603. Jpn J Clin Oncol. 39:406–409. 2009. View Article : Google Scholar
|
|
3
|
Polyzos A, Tsavaris N, Gogas H, et al:
Clinical features of hypersensitivity reactions to oxaliplatin: a
10-year experience. Oncology. 76:36–41. 2008.PubMed/NCBI
|
|
4
|
Earle CC, Chen WY, Ryan DP and Mayer RJ:
Oxaliplatin-induced Evan’s syndrome. Br J Cancer. 84:4412001.
|
|
5
|
Sorbye H, Bruserud O and Dahl O:
Oxaliplatin-induced haematological emergency with an immediate
severe thrombocytopenia and haemolysis. Acta Oncol. 40:882–883.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yasuhara E, Nitta Y, Yasuda K, Maruyama M
and Akazai Y: Two cases of Oxaliplatin-induced thrombocytopenia.
Jpn J Clin Surg. 71:913–917. 2010. View Article : Google Scholar
|
|
7
|
Pietrantonio F, Di Bartolomeo M, Buzzoni R
and Bajetta E: Acute immune-mediated thrombocytopenia due to
oxaliplatin administration: a case report. Tumori. 96:154–156.
2010.PubMed/NCBI
|
|
8
|
Bautista MA, Stevens WT, Chen CS, Curtis
BR, Aster RH and Hsueh CT: Hypersensitivity reaction and acute
immune-mediated thrombocytopenia from oxaliplatin: two case reports
and a review of the literature. J Hematol Oncol. 26:3–12.
2010.PubMed/NCBI
|
|
9
|
Shao YY and Hong RL: Fatal
thrombocytopenia after oxaliplatin-based chemotherapy. Anticancer
Res. 28:3115–3118. 2008.PubMed/NCBI
|
|
10
|
Taleghani BM, Meyer O, Fontana S, et al:
Oxaliplatin-induced immune pancytopenia. Transfusion. 45:704–708.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Curtis BR, Kaliszewski J, Marques MB, et
al: Immune-mediated thrombocytopenia resulting from sensitivity to
oxaliplatin. Am J Hematol. 81:199–201. 2006. View Article : Google Scholar
|
|
12
|
Dold FG and Mitchell EP: Sudden-onset
thrombocytopenia with oxaliplatin. Ann Intern Med. 139:156–157.
2003.PubMed/NCBI
|
|
13
|
Koutras AK, Makatsoris M, Paliogianni F,
et al: Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage
and hemolysis. Oncology. 67:179–182. 2004. View Article : Google Scholar : PubMed/NCBI
|
